Hemolytic and uremic syndrome;Syndrome hémolytique et urémique de l'adulte

Nephrologie

Volumn 23, Issue 4, 2002, Pages 165-171

  Vigneau, Cécile ^a   Rondeau, Eric ^a  

^a HÔPITAL TENON   (France)

Author keywords

Acute renal failure; Hemolytic uremic syndrome; Treatment

Indexed keywords

COMPLEMENT FACTOR H; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FRESH FROZEN PLASMA; IMMUNOGLOBULIN; STEROID; VINCRISTINE;

ACUTE KIDNEY FAILURE; ADULT; AGE DISTRIBUTION; ANTIHYPERTENSIVE THERAPY; CANCER; CASE REPORT; CHEMOTHERAPY; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; COMPLEMENT DEFICIENCY; CORTICOSTEROID THERAPY; DISEASE COURSE; FEMALE; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERTENSION; IMMUNOTHERAPY; INTESTINE OBSTRUCTION; PLASMA TRANSFUSION; PLASMAPHERESIS; PREGNANCY; RECURRENT DISEASE; RENOVASCULAR HYPERTENSION; REVIEW; SPLENECTOMY; SYSTEMIC DISEASE; TREATMENT OUTCOME;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; HYPERTENSION; MIDDLE AGED; PLASMA EXCHANGE;

EID: 0036088876     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Haemolytic-uraemic syndrome in practice
2. How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
3. Haemolytic-uraemic syndrome and thrombotic: Thrombocytopenic purpura - New insights into underlying biochemical mechanism
4. Von Willebrand factor in thrombotic thrombocytopenic purpura
5. Thrombotic microangiopathies including hemolytic uremic syndrome
6. Binding and transfer of verototoxin by polynuclear leukocytes in hemolytic uremic syndrom
7. Clopidogrel-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in a kidney/pancreas transplant recipient
8. Remuzzi on behalf of the registry of familial and recurrent HUS/TTR. Increased fragmentation of von Willebrand factor, due to abnormal cleavage of the subunit, parallels disease activity in recurrent hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and discloses predisposition in families
9. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome
10. Human complement factor H deficiency associated with hemolytic uremic syndrome
11. Familial hemolytic-uremic syndrome and homozygous factor H deficiency
12. Are HUS and TTP genetically determined?
13. Factor H-US?
14. Hemolytic uremic syndrome: Past and present
15. Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic throbocytopenic purpura. Role of factor H abnormalities
16. Antibodies to Von Willebrand factor-cleaving protease in acute thrombocytopenic purpura
17. Hemolytic uremic syndrome. Recurrence after renal transplantation
18. Renal transplantation in adults with thrombotic thrombocytopenic purpura/hemolytic-uraemic syndrome
19. Unrecognized pattern of Von Willebrand factor abnormalities in hemolytic and uremic syndrome and thrombotic thrombocytopenic purpura
20. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
21. Structure of Von Willebrand factor-cleaving protease (ADAMTS 13), a metalloprotease involved in thrombotic thrombocytopenic purpura
22. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family
23. Haemolytic-uraemic syndrome: Basic science
24. The clinical pathological characteristics and outcome in hemolytic and uremic syndrome of adults
25. The diagnostic yield of transjugular renal biopsy. Experience in 200 cases
26. Transjugular versus percutaneous renal biopsy for the diagnosis of parenchymal disease: Comparaison of sampling effectiveness and complications
27. Effectiveness of therapeutic exchange in the 1996 Lanarkshire Escherichia coil O157:H7 outbreak
28. FK-506-associated thrombotic microangiopathy
29. Quinine-induced immune thrombocytopenic purpura followed by hemolytic uremic syndrome
30. Quinine-induced hemolytic-uremic syndrome
31. A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy
32. Renal thrombotic microangiopathie induced by interferon-α
33. Hemolytic uremic syndrome associated with influenza A virus infection in an adult renal allograft recipient: Case report and review of the litterature
34. De novo hemolytic uremic syndrome postrenal transplant after cytomegalovirus infection
35. Acute renal failure in the course of HIV infection: A single-institution retrospective study of ninety-two patients and sixty renal biopsies
36. Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura: Hemolytic uremic syndrome in the cancer patient
37. Haemolytic-uremic syndrome and thrombotic-thrombocytopenic purpura in adults: Clinical findings and prognostic factors for death and end stage renal disease
38. Hemolyticuremic syndrome caused by mitomycin C: Long term management
39. Thrombotic microangiographic hemolytic anemia in systemic lupus erythematosus
40. Hemolytic urernic syndrome associated with immunoglobulin A nephropathy: A case report and review of cases of hemolytic yremic syndrome with glomerular disease
41. Hemolytic uremic syndrome complicating postinfectious glomerulonephritis in the adult
42. Hemolytic uremic syndrome associated with glomerular disease
43. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections
44. Effects of early fosfomycine treatment on prevention of hemolytic uremic syndrome accompanying Escherichia Coli O157:H7 infection
45. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura
46. Improved survival on thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
47. Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome
48. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: Diagnosis and management
49. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: A multivariate analysis of factors predicting the response to plasma exchange
50. Pathophysiology and management of thrombotic microangiopathies
51. Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome